INTANGIBLE ASSET |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| INTANGIBLE ASSET | |
| INTANGIBLE ASSET | NOTE 8 – INTANGIBLE ASSET
The Company capitalized the costs associated with acquiring the exclusive worldwide license to develop and commercialize products comprising or containing the compound ART27.13 as an intangible asset at a value of $2,039 as of June 30, 2026, and December 31, 2025.
The amount capitalized consisted of a $1,500 payment and the fair value of 227 shares of common stock of $539. During the six months ended June 30, 2026, no additional costs met the criteria for capitalization as an intangible asset. |